Search Results - Kurasaki, Tohri

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    WT1 peptide vaccination in combination with imatinib therapy for a patient with CML in the chronic phase

    WT1 peptide vaccination in combination with imatinib therapy for a patient with CML in the chronic phase by Narita, Miwako, Masuko, Masayoshi, Kurasaki, Tohri, Kitajima, Toshiki, Takenouchi, Shoko, Saitoh, Anri, Watanabe, Norihiro, Furukawa, Tatsuo, Toba, Ken, Fuse, Ichiro, Aizawa, Yoshifusa, Kawakami, Manabu, Oka, Yoshihiro, Sugiyama, Haruo, Takahashi, Masuhiro

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group)

    A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of... by Takizawa, Jun, Aoki, Sadao, Takai, Kazue, Kurasaki, Tohri, Honma, Keiichiro, Higashimura, Masutaka, Nagai, Kouichi, Momoi, Akihito, Nikkuni, Koji, Aizawa, Yoshufusa

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: